| __timestamp | Iovance Biotherapeutics, Inc. | Viatris Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 2704597 | 581800000 |
| Thursday, January 1, 2015 | 15470000 | 671900000 |
| Friday, January 1, 2016 | 28037000 | 876700000 |
| Sunday, January 1, 2017 | 71615000 | 857900000 |
| Monday, January 1, 2018 | 99828000 | 822200000 |
| Tuesday, January 1, 2019 | 166023000 | 778200000 |
| Wednesday, January 1, 2020 | 201727000 | 512600000 |
| Friday, January 1, 2021 | 259039000 | 681000000 |
| Saturday, January 1, 2022 | 294781000 | 662200000 |
| Sunday, January 1, 2023 | 344077000 | 910700000 |
In pursuit of knowledge
In the ever-evolving landscape of biotechnology and pharmaceuticals, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, Viatris Inc. and Iovance Biotherapeutics, Inc. have demonstrated contrasting approaches to R&D investment.
Viatris Inc. has consistently allocated a significant portion of its resources to R&D, with expenditures peaking in 2023. This represents a 56% increase from 2014, underscoring the company's dedication to maintaining its competitive edge.
Conversely, Iovance Biotherapeutics, Inc. has shown a remarkable surge in R&D spending, skyrocketing by over 12,600% from 2014 to 2023. This aggressive investment strategy highlights Iovance's ambition to pioneer groundbreaking therapies.
As these companies continue to innovate, their R&D investments will likely shape the future of healthcare.
Who Prioritizes Innovation? R&D Spending Compared for Amgen Inc. and Iovance Biotherapeutics, Inc.
Comparing Innovation Spending: Incyte Corporation and Viatris Inc.
Research and Development Investment: Viatris Inc. vs Corcept Therapeutics Incorporated
Who Prioritizes Innovation? R&D Spending Compared for Viatris Inc. and ACADIA Pharmaceuticals Inc.
Comparing Innovation Spending: Viatris Inc. and HUTCHMED (China) Limited
Who Prioritizes Innovation? R&D Spending Compared for Viatris Inc. and Supernus Pharmaceuticals, Inc.
SG&A Efficiency Analysis: Comparing Viatris Inc. and Iovance Biotherapeutics, Inc.
Viatris Inc. or Amphastar Pharmaceuticals, Inc.: Who Invests More in Innovation?
Grifols, S.A. or Iovance Biotherapeutics, Inc.: Who Invests More in Innovation?
Analyzing R&D Budgets: CRISPR Therapeutics AG vs Iovance Biotherapeutics, Inc.
R&D Spending Showdown: Catalyst Pharmaceuticals, Inc. vs Iovance Biotherapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Protagonist Therapeutics, Inc. and Iovance Biotherapeutics, Inc.